NovaBridge Biosciences (NBP) Receivables Refunds (2021 - 2023)

NovaBridge Biosciences (NBP) has 3 years of Receivables Refunds data on file, last reported at $652215.2 in Q4 2023.

• Quarterly Receivables Refunds fell 43.41% year-over-year to $652215.2 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $652215.2 (down 43.41% YoY) and the FY2023 annual result came in at $661000.0, down 44.36% from the prior year.
• Receivables Refunds declined to $652215.2 in Q4 2023 per NBP's latest filing, from $1.2 million in the prior quarter.
• Across five years, Receivables Refunds topped out at $14.0 million in Q4 2021 and bottomed at $652215.2 in Q4 2023.
• The 3-year median for Receivables Refunds is $1.2 million (2022), against an average of $5.3 million.
• The widest annual swing landed in 2022, when Receivables Refunds plunged 91.77%; it then plunged 43.41% in 2023.
• Tracing NBP's Receivables Refunds over 3 years: stood at $14.0 million in 2021, then sank by 91.77% to $1.2 million in 2022, then slumped by 43.41% to $652215.2 in 2023.
• Per Business Quant, the three latest NBP Receivables Refunds figures stand at $652215.2 (Q4 2023), $1.2 million (Q4 2022), and $14.0 million (Q4 2021).

Peer Comparison